Libra Infusions (DHA:LIBRAINFU) Long-Term Debt: BDT0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
21 GF Score
Price BDT643.90
View Full Analysis

What is Libra Infusions Long-Term Debt?

Libra Infusions DHA:LIBRAINFU -0.20% 21 Long-Term Debt is BDT0.00 Mil as of . 20. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 21/100.

Libra Infusions's Long-Term Debt for the quarter that ended in . 20 was BDT0.00 Mil.

Libra Infusions  (DHA:LIBRAINFU) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Libra Infusions Long-Term Debt Related Terms

Libra Infusions Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Long-Term Debt Chart

Libra Infusions Annual Data
Trend
Long-Term Debt

Libra Infusions Semi-Annual Data
Long-Term Debt
DHA:LIBRAINFU
21GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of BDT0.00 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Long-Term Debt of BDT0.00 Mil as of . 20.
Is Libra Infusions' Long-Term Debt too high?
Libra Infusions' current Long-Term Debt is BDT0.00 Mil. Overall, Libra Infusions has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Long-Term Debt compare to SECI and LENSF?
Libra Infusions' Long-Term Debt of BDT0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Libra Infusions's current Long-Term Debt is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Long-Term Debt of BDT0.00 Mil. The current Long-Term Debt is BDT0.00 Mil. Libra Infusions' overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Long-Term Debt is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
21GF Score

Get the complete analysis for DHA:LIBRAINFU

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT643.90
Price